ArticleNature communications2017
A volumetric three-dimensional digital light photoactivatable dye display.
Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- A Reversible 900 nm Near-Infrared Photoswitch for Invisibly Writable 2D and 3D Displays.Angewandte Chemie (International ed. in English) · 2026Article
- Reversible single crystal photochemistry and spin state switching in a metal-cyanide complex.Nature communications · 2025Article
- Split-Aperture Xolography - Linear Volumetric Photoactivation with Short Axial Dimension and Low out of Focus Excitation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Activation of Perovskite Nanocrystals for Volumetric Displays Using Near-Infrared Photon Upconversion by Triplet Fusion.Molecules (Basel, Switzerland) · 2025Article
- Full-color dynamic volumetric displays with tunable upconversion emission from RELight, science & applications · 2025Article
- Development of a solid-supported light-triggered nitric oxide donor.Journal of photochemistry and photobiology. A, Chemistry · 2024Article
- Luminescent Materials for Volumetric Three-Dimensional Displays Based on Photoactivated Phosphorescence.Polymers · 2023Article
- Spirocyclic rhodamine B benzoisothiazole derivative: a multi-stimuli fluorescent switch manifesting ethanol-responsiveness, photo responsiveness, and acidochromism.RSC advances · 2023Article
- Visible Light Chemical Micropatterning Using a Digital Light Processing Fluorescence Microscope.ACS central science · 2022Article
- Seeking Illumination: The Path to Chemiluminescent 1,2-Dioxetanes for Quantitative Measurements andAccounts of chemical research · 2021Article
- Xolography for linear volumetric 3D printing.Nature · 2020Article
- Planarization-Induced Activation Wavelength Red-Shift and Thermal Half-Life Acceleration in Hydrazone Photoswitches.ChemistryOpen · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Volumetric three-dimensional displays offer spatially accurate representations of images with a 360° view, but have been difficult to implement due to complex fabrication requirements. Herein, a chemically enabled volumetric 3D digital light photoactivatable dye display (3D Light PAD) is reported. The operating principle relies on photoactivatable dyes that become reversibly fluorescent upon illumination with ultraviolet light. Proper tuning of kinetics and emission wavelengths enables the generation of a spatial pattern of fluorescent emission at the intersection of two structured light beams. A first-generation 3D Light PAD was fabricated using the photoactivatable dye N-phenyl spirolactam rhodamine B, a commercial picoprojector, an ultraviolet projector and a custom quartz imaging chamber. The system displays a minimum voxel size of 0.68 mm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.